- Home
- CRDF vs EPSN Comparison
CRDF vs EPSN Comparison
Compare CRDF & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRDF | EPSN |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.1M | 132.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRDF | EPSN |
|---|---|---|
| Price | $2.16 | $4.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.63 | N/A |
| AVG Volume (30 Days) | ★ 730.8K | 166.4K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 5.00% |
| EPS Growth | N/A | ★ 11.33 |
| EPS | N/A | ★ 0.27 |
| Revenue | $501,000.00 | ★ $45,709,605.00 |
| Revenue This Year | N/A | $41.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.85 |
| Revenue Growth | N/A | ★ 46.76 |
| 52 Week Low | $1.90 | $4.36 |
| 52 Week High | $5.64 | $8.50 |
Technical Indicators
Market Signals| Indicator | CRDF | EPSN |
|---|---|---|
| Relative Strength Index (RSI) | 50.06 | 57.14 |
| Support Level | $2.03 | $4.66 |
| Resistance Level | $2.37 | $4.88 |
| Average True Range (ATR) | 0.12 | 0.18 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 55.32 | 85.71 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.